Geraldine T. Farrell is VP Operations & General Counsel at Nexvet Biopharma plc (NVET). They have made 1 open-market trade across 1 company since 2016, most recently 2017-07-31.
CIK 0001632385
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVET | 18,980 | $128K |
Shares reported on the most recent Form 4, priced at the 2017-07-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVET | SELL | 2016-03-03 | 2016-03-17 | $3.27 | $432 | +6.4% | +1.3% | +34.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.